Publikationen (43) Publikationen von Esther Moreno Amatria

2024

  1. Bioadhesive gel containing 5 % acyclovir for the treatment of herpes labialis: Preclinical development

    Journal of Drug Delivery Science and Technology, Vol. 100

  2. Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  3. Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles

    Frontiers in Immunology, Vol. 15

2023

  1. Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment

    Molecules, Vol. 28, Núm. 15

  2. Next generation of selenocyanate and diselenides with upgraded leishmanicidal activity

    Bioorganic Chemistry, Vol. 138

  3. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

  4. Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

    Antioxidants, Vol. 12, Núm. 1

2022

  1. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  2. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments

    Pharmaceuticals, Vol. 15, Núm. 12

  3. Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 14, Núm. 11

  4. Unveiling a New Selenocyanate as a Multitarget Candidate with Anticancer, Antileishmanial and Antibacterial Potential

    Molecules, Vol. 27, Núm. 21

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  3. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  4. New amides and phosphoramidates containing selenium: Studies on their cytotoxicity and antioxidant activities in breast cancer

    Antioxidants, Vol. 10, Núm. 4

  5. New amides containing selenium as potent leishmanicidal agents targeting trypanothione reductase

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  6. New phosphoramidates containing selenium as leishmanicidal agents

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 10

  7. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

  8. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18